Popular Keywords
Acute Leukemia
Chemotherapy
Hematology
Hematopoiesis
Interferon therapy
Leukemia virus
Editorial-Board
- Arthur S. Berg, PhD
University of California, USA - S.Hamid Sayar, PhD
Indiana University, Indianapolis, United States - Kenneth Draper, PhD
International Scientific Associates, LLC, Reno, US - Fengyan Jin, PhD
The First Hospital of Jilin University, China - Vittorio Montefusco
University of Bologna, Italy - Anna Aureli
CNR, Institute of Translational Pharmacology (ITF), Italy - Ludomira H.Granicka, PhD
Nalecz Institute of Biocybernetics & Biomedical Eng., Poland - Monika Lejman Onet, PhD
Lublin, Medical School, Poland - Ramasamy Harikrishnan, PhD
Bharathidasan University, India - Huseyin Engin
Bulent Ecevit University The School of Medicine, Turkey - Minodora-Cezarina Onisai, MD, PhD
Emergency University Hospital Elias, Romania - Gaafar Mohamed Abdel-Rasoul
Menoufia University, Egypt - Mohammad Ali Mashhadi
Zahedan Univercity Of Medical Science, Iran - Ladan Langroudi, PhD
Kerman University of medical sciences, Iran - Marwan A.Masri, PhD
Transmedical For Life, Lebanon - Yao Dai
University of Florida, Gainesville - Salam Salim Alkindi
Sultan Qaboos University, Oman
Journal Info
- Journal Name: Journal of Leukemia Research
- Impact Factor: 1.6
- ISSN: 2831-3186
- DOI: 10.52338/ Jolr
- Short Name: JOLR
- Acceptance rate: 55%
- Volume: 6 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
INDEXING
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility